CSIMarket
 


China Biologic Products Holdings Inc   (CBPO)
Other Ticker:  
 

China Biologic Products Holdings Inc 's Quick Ratio

CBPO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




CBPO Quick Ratio (Dec 31 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Current Liabilities Change -2.48 % -2.48 % -2.48 % -2.48 % 25.31 %
Y / Y Cash & cash equivalent Change -83.02 % -83.02 % -83.02 % -83.02 % 293.18 %
Quick Ratio MRQ 1.36 1.36 1.36 1.36 7.78
Overall Ranking # 1448 # 1454 # 1448 # 0 # 428
Seq. Current Liabilities Change 0 % 0 % 0 % -2.48 % 0 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -83.02 % 0 %



Quick Ratio forth quarter 2019 Comment
Regardless of the sequential decrease in Current Liabilities, Quick Ratio detoriated to 1.36 below company average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 141 other companies have achieved higher Quick Ratio than China Biologic Products Holdings Inc in forth quarter 2019. While Quick Ratio total ranking has improved so far to 1448, from total ranking in previous quarter at 1454.

Explain Quick Ratio?
What are CBPO Segments?
See Quick Ratio CBPO on the trailing twelve month basis
Quick Ratio forth quarter 2019 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 142
Healthcare Sector # 565
Overall Market # 1448


Quick Ratio Statistics
High Average Low
7.78 2.91 1.07
(Dec 31 2018)   (Sep 30 2014)




Financial Statements
China Biologic Products Holdings Inc 's Current Liabilities $ 119 Millions Visit CBPO's Balance sheet
China Biologic Products Holdings Inc 's Cash & cash equivalent $ 162 Millions Visit CBPO's Balance sheet
Source of CBPO's Sales Visit CBPO's Sales by Geography


Cumulative China Biologic Products Holdings Inc 's Quick Ratio

CBPO's Quick Ratio for the trailling 12 Months

CBPO Quick Ratio

(Dec 31 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Current Liabilities TTM Growth -2.48 % -2.48 % -2.48 % -2.48 % 25.31 %
Y / Y Cash & cash equivalent TTM Growth -83.02 % -83.02 % -83.02 % -83.02 % 293.18 %
Quick Ratio TTM 1.36 2.99 4.61 6.21 7.78
Total Ranking TTM # 1323 # 1328 # 0 # 0 # 164
Seq. Current Liabilities TTM Growth 0 % 0 % 0 % -2.48 % 0 %
Seq. Cash & cash equivalent TTM Growth 0 % 0 % 0 % -83.02 % 0 %


TTM Quick Ratio Comment
On the trailing twelve months basis In spite of the year on year decrease in CBPO's average Current Liabilities to $119.31 millions, Quick Ratio to 1.36 below company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 135 other companies have achieved higher Quick Ratio than China Biologic Products Holdings Inc . While overall ranking remained unchanged compare to previous quarter at no. 1323.

Explain Quick Ratio?
What are CBPO Segments?
See Quick Ratio CBPO on the trailing twelve month basis

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 136
Healthcare Sector # 549
Within the Market # 1323


TTM Quick Ratio Statistics
High Average Low
7.78 2.48 1.25
(Dec 31 2018)   (March 31, 2015)




Companies with similar Quick Ratio in the quarter ending Dec 31 2019, within Biotechnology & Pharmaceuticals Industry Quick RatioDec 31 2019 MRQ Cash & cash equivalentDec 31 2019 MRQ Current Liabilities
Htg Molecular Diagnostics Inc  3.71 $ 33.030  Millions$ 8.899  Millions
Aerie Pharmaceuticals Inc   3.70 $ 309.190  Millions$ 83.648  Millions
Erytech Pharma S.a.  3.68 $ 81.954  Millions$ 22.267  Millions
Natural Health Trends Corp   3.65 $ 96.035  Millions$ 26.302  Millions
Fate Therapeutics Inc   3.59 $ 99.814  Millions$ 27.806  Millions
Dbv Technologies S a   3.58 $ 192.670  Millions$ 53.836  Millions
Sutro Biopharma Inc   3.58 $ 117.864  Millions$ 32.967  Millions
La Jolla Pharmaceutical Company  3.57 $ 87.820  Millions$ 24.587  Millions
Lifeloc Technologies Inc   3.53 $ 3.186  Millions$ 0.902  Millions
Vericel Corporation  3.52 $ 69.718  Millions$ 19.795  Millions
Immucell Corp  3.52 $ 8.774  Millions$ 2.495  Millions
Nanovibronix Inc  3.27 $ 1.338  Millions$ 0.409  Millions
Curis Inc   3.22 $ 20.543  Millions$ 6.375  Millions
Novavax inc   3.17 $ 81.770  Millions$ 25.795  Millions
Intuitive Surgical Inc   3.13 $ 3,221.700  Millions$ 1,030.200  Millions
Seagen Inc   3.13 $ 811.055  Millions$ 259.357  Millions
Alpha Pro Tech Ltd   2.99 $ 6.883  Millions$ 2.303  Millions
Windtree Therapeutics Inc  2.89 $ 22.578  Millions$ 7.817  Millions
Allena Pharmaceuticals Inc.  2.88 $ 30.007  Millions$ 10.410  Millions
Coherus Biosciences inc   2.78 $ 177.668  Millions$ 63.849  Millions
Heska Corporation  2.76 $ 89.030  Millions$ 32.199  Millions
Pluri Inc   2.76 $ 16.651  Millions$ 6.027  Millions
Nexien Biopharma Inc   2.62 $ 0.049  Millions$ 0.019  Millions
Adaptimmune Therapeutics Plc  2.61 $ 89.542  Millions$ 34.341  Millions
Cardiff Oncology inc   2.60 $ 10.195  Millions$ 3.916  Millions
Health Discovery Corporation  2.60 $ 2.300  Millions$ 0.885  Millions
Mosaic Immunoengineering Inc   2.58 $ 1.140  Millions$ 0.442  Millions
Cel sci Corporation  2.42 $ 11.054  Millions$ 4.566  Millions
Atyr Pharma Inc   2.41 $ 31.144  Millions$ 12.923  Millions
Bio techne Corp  2.32 $ 243.950  Millions$ 104.953  Millions

Date modified: 2022-05-19T16:22:37+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BLNK's Profile

Stock Price

BLNK's Financials

Business Description

Fundamentals

Charts & Quotes

BLNK's News

Suppliers

BLNK's Competitors

Customers & Markets

Economic Indicators

BLNK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071